SciTech Strategies Inc., Albuquerque, NM, 87122, USA.
Eur J Clin Invest. 2013 Dec;43(12):1339-65. doi: 10.1111/eci.12171. Epub 2013 Oct 21.
We have generated a list of highly influential biomedical researchers based on Scopus citation data from the period 1996-2011. Of the 15,153,100 author identifiers in Scopus, approximately 1% (n=149,655) have an h-index >=20. Of those, we selected 532 authors who belonged to the 400 with highest total citation count (>=25,142 citations) and/or the 400 with highest h-index (>=76). Of those, we selected the top-400 living core biomedical researchers based on a normalized score combining total citations and h-index. Another 62 authors whose focus is outside biomedicine had a normalized score that was at least as high as the score of the 400th core biomedical researcher. We provide information on the profile of these most influential authors, including the most common Medical Subject Heading terms in their articles that are also specific to their work, most common journals where they publish, number of papers with over 100 citations that they have published as first/single, last, or middle authors, and impact score adjusted for authorship positions, given that crude citation indices and authorship positions are almost totally orthogonal. We also show for each researcher the distribution of their papers across 4 main levels (basic-to-applied) of research. We discuss technical issues, limitations and caveats, comparisons against other lists of highly-cited researchers, and potential uses of this resource.
我们根据 Scopus 1996-2011 年的引文数据生成了一份高影响力生物医学研究人员名单。在 Scopus 的 15153100 个作者标识符中,约有 1%(n=149655)的 h-index>=20。在这些人中,我们选择了 532 位作者,他们属于总引用数最高的 400 位(>=25142 次引用)和/或 h-index 最高的 400 位(>=76)。在这些人中,我们根据综合总引用数和 h-index 的归一化分数选择了前 400 位活跃的核心生物医学研究人员。另有 62 位作者的研究重点不在生物医学领域,但他们的归一化分数至少与第 400 位核心生物医学研究人员的分数一样高。我们提供了这些最有影响力的作者的简介信息,包括他们文章中最常见的医学主题词,这些词也与他们的工作相关,他们最常发表文章的期刊,他们作为第一/单一、最后或中间作者发表的超过 100 次引用的论文数量,以及根据作者位置调整的影响分数,因为原始引文指数和作者位置几乎完全正交。我们还为每位研究人员展示了他们的论文在 4 个主要研究层次(基础到应用)上的分布情况。我们讨论了技术问题、局限性和注意事项,以及与其他高引用研究人员名单的比较,并介绍了该资源的潜在用途。
Eur J Clin Invest. 2013-10-21
Rev Invest Clin. 2013
World J Surg. 2002-9
Orv Hetil. 2007-5-6
Pediatr Transplant. 2017-6
Proc Natl Acad Sci U S A. 2018-3-13
BioData Min. 2016-11-9
Nature. 2014-10-30
PLoS Med. 2014-10-21